Subscribe free

Upper Gastrointestinal Tract ·

Pretreatment Pan-Immune-Inflammation Value Predicts Neoadjuvant Immunochemotherapy Outcomes for Esophageal Cancer

Researchers assessed the Pan-Immune-Inflammation Value (PIV) as an indicator of neoadjuvant immunochemotherapy (NICT) response in esophageal squamous cell carcinoma. Among 218 patients, PIV was linked to achieving a pathological complete response. High PIV predicted poorer 3-year overall survival and disease-free survival compared to low PIV. PIV independently forecasted outcomes. A novel risk stratification model improved prognosis accuracy. This suggests that pretreatment PIV is a sensitive predictor for NICT effectiveness in esophageal cancer. Further prospective studies are needed to confirm these prognostic results.

Journal Article by Feng J, Wang L (…) Cheng X et 2 al. in Ann Surg Oncol

© 2023. Society of Surgical Oncology.

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in Upper Gastrointestinal Tract.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

Specialty newsletters: every new paper in your field, as a list of titles linked to the source. Daily Selection: the five that matter, cut to their key points.

FreeNo spamOne-click unsubscribe

More in Upper Gastrointestinal Tract

The latest stitches

Ann Surg Oncol2 Nov 2026

High symptom burden after oesophagectomy

On postoperative day 3, about one in five patients had high symptom burden, and the symptoms most linked to others differed between patient groups.

J Gastrointest Cancer23 Oct 2026

Uniportal esophagectomy linked to fewer pneumonias

In nine comparative studies of minimally invasive esophagectomy for esophageal cancer, uniportal VATS was associated with less pneumonia and a shorter stay than multiportal VATS—but the evidence is not strong enough to establish a preferred approach.

All papers in Upper Gastrointestinal Tract →